From a long-term perspective, $MOH (-0,05%) continues to be an attractive roll-up strategy that can benefit from adding smaller single-state health insurers to its platform.
Molina's attractive valuation, cost control strategies, and growth outlook make it a potential buy for investors looking for long-term rewards.
